Skip to Main Content

Author Details

Lixin Lang
First Hospital of Shanxi Medical University, Shanxi Medical University
1989
103
37
PMIDPaper TitleJournal TitlePublished Year
37284102Comparative study of the quantitative accuracy of oncological PET imaging based on deep learning methods.Quant Imaging Med Surg2023
35218944Evaluation of the TruSight Oncology 500 Assay for Routine Clinical Testing of Tumor Mutational Burden and Clinical Utility for Predicting Response to Pembrolizumab.J Mol Diagn2022
35606352A genetic engineering strategy for editing near-infrared-II fluorophores.Nat Commun2022
35885960Effect of Developmental Stages on Genes Involved in Middle and Downstream Pathway of Volatile Terpene Biosynthesis in Rose Petals.Genes (Basel)2022
35101941Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors.J Immunother Cancer2022
34088264Integrated metabolome and transcriptome analysis of the anthocyanin biosynthetic pathway in relation to color mutation in miniature roses.BMC Plant Biol2021
33801551Metabolome-Based Discrimination Analysis of Five <i>Lilium</i> Bulbs Associated with Differences in Secondary Metabolites.Molecules2021
32145257[<sup>18</sup>F]-Alfatide PET imaging of integrin αvβ3 for the non-invasive quantification of liver fibrosis.J Hepatol2020
31880916Combined <sup>68</sup>Ga-NOTA-Evans Blue Lymphoscintigraphy and <sup>68</sup>Ga-NOTA-RM26 PET/CT Evaluation of Sentinel Lymph Node Metastasis in Breast Cancer Patients.Bioconjug Chem2020
33299586First report of <sup>68</sup>Ga-PRGD2 PET/MRI molecular imaging of vaso-occlusion in a patient with sickle cell disease.BJR Case Rep2020
30300471Antidiabetic Effect of Abextide, a Long-Acting Exendin-4 Analogue in Cynomolgus Monkeys.Adv Healthc Mater2019
31270559<sup>68</sup>Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma.Eur J Nucl Med Mol Imaging2019
31181890Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.Bioconjug Chem2019
31593447A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.Bioconjug Chem2019
30867836A Logic-Gated Modular Nanovesicle Enables Programmable Drug Release for On-Demand Chemotherapy.Theranostics2019
31117347An Albumin-Binding T<sub>1</sub>- T<sub>2</sub> Dual-Modal MRI Contrast Agents for Improved Sensitivity and Accuracy in Tumor Imaging.Bioconjug Chem2019
31082207An Albumin Sandwich Enhances in Vivo Circulation and Stability of Metabolically Labile Peptides.Bioconjug Chem2019
29123014PET Using a GRPR Antagonist <sup>68</sup>Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.J Nucl Med2018
30105912Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors.Bioconjug Chem2018
30052597Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma.Clin Nucl Med2018
3003625368Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study.Clin Nucl Med2018
29721096First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using <sup>68</sup>Ga-IRDye800CW-BBN.Theranostics2018
29664214Predictive probability methods for interim monitoring in clinical trials with longitudinal outcomes.Stat Med2018
29464003<sup>68</sup>Ga-BBN-RGD PET/CT for GRPR and Integrin α<sub>v</sub>β<sub>3</sub> Imaging in Patients with Breast Cancer.Theranostics2018
29254329Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN<sub>7-14</sub> and Antagonist RM26.Bioconjug Chem2018
27493267Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD.J Nucl Med2017
28434648Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.Lancet2017
28382512Microsurgery guided by sequential preoperative lymphography using <sup>68</sup>Ga-NEB PET and MRI in patients with lower-limb lymphedema.Eur J Nucl Med Mol Imaging2017
29203865Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.Nat Commun2017
28744320Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography.Theranostics2017
26877782Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding.Theranostics2016
2644983868Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.J Nucl Med2016
26641886Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment.Bioconjug Chem2016
27149392A photothermally responsive nanoprobe for bioimaging based on Edman degradation.Nanoscale2016
25535368In vivo albumin labeling and lymphatic imaging.Proc Natl Acad Sci U S A2015
26251416Clinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB.J Nucl Med2015
2642995868Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer.J Nucl Med2015
26121930(18)F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases.Eur J Nucl Med Mol Imaging2015
25896816Quantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET.Mol Imaging Biol2015
23982795Comparison of three dimeric 18F-AlF-NOTA-RGD tracers.Mol Imaging Biol2014
24842890In Vivo Labeling of Serum Albumin for PET.J Nucl Med2014
24533430Stability analysis of glutamic acid linked peptides coupled to NOTA through different chemical linkages.Mol Pharm2014
24672585Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors.Theranostics2014
24266806Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity.ACS Chem Biol2014
24232871(18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.J Nucl Med2014
23342300One-step and one-pot-two-step radiosynthesis of cyclo-RGD-(18)F-aryltrifluoroborate conjugates for functional imaging.Am J Nucl Med Mol Imaging2013
23750453Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.Bioconjug Chem2013
23554506First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination.J Nucl Med2013
22109665PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model.Eur J Nucl Med Mol Imaging2012
23139087PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury.J Nucl Med2012
  • 1 - 50 of 103

Recommended Authors

Milan Grkovski
Memorial Sloan Kettering Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Vincenzo Paolillo
UT MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 1
Peter J H Scott
University of Michigan Medical School ann arbor
Career Start Year 2007
Number of shared co-authors 2
Marc D Normandin
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Career Start Year 2005
Number of shared co-authors 3
Youngho Seo
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 0
Natasja G Lieuwes
Maastricht University
Career Start Year 2003
Number of shared co-authors 0
Steven W Millward
University of Texas MD Anderson Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Niki M Zacharias
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Nobuyuki Kosaka
University of Fukui.
Career Start Year 1997
Number of shared co-authors 2
Neeta Pandit-Taskar
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Leo G Flores
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Mian M Alauddin
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Juri G Gelovani
Karmanos Cancer Institute (KCI), Wayne State University
Career Start Year 1990
Number of shared co-authors 0
Magnus Dahlbom
David Geffen School of Medicine, university of california los angeles
Career Start Year 1988
Number of shared co-authors 1
Johannes Czernin
university of california los angeles
Career Start Year 1987
Number of shared co-authors 1
John J Sunderland
University of Iowa
Career Start Year 1986
Number of shared co-authors 1
John L Humm
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 2
James P Basilion
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 0
Michael J Adam
University of Washington School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Jogeshwar Mukherjee
Preclinical Imaging, University of California-Irvine
Career Start Year 1984
Number of shared co-authors 1
Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Career Start Year 1983
Number of shared co-authors 3
Jiahe Tian
First Medical Center of Chinese PLA General Hospital
Career Start Year 1982
Number of shared co-authors 6
James R Bading
City of Hope National Medical Center
Career Start Year 1982
Number of shared co-authors 2
Chaitanya Divgi
Columbia University Medical Center Kreitchman PET Center
Career Start Year 1981
Number of shared co-authors 1
Chester A Mathis
University of Pittsburgh
Career Start Year 1981
Number of shared co-authors 0
Robert B Innis
National Institute of Mental Health
Career Start Year 1978
Number of shared co-authors 1
Pradeep K Garg
Wake Forest University School of Medicine
Career Start Year 1972
Number of shared co-authors 1
Peter S Conti
Keck School of Medicine of USC
Career Start Year 1971
Number of shared co-authors 4

Collaborators

Xiaoyuan Chen
Institute of Molecular and Cell Biology
Co-authored papers 54
Dale O Kiesewetter
National Institute of Biomedical Imaging and Bioengineering
Co-authored papers 47
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Co-authored papers 43
Ying Ma
National Institutes of Health
Co-authored papers 42
Ning Guo
Beijing Tongren Hospital, Capital Medical University
Co-authored papers 13
Zhaohui Zhu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Co-authored papers 13
Richard E Carson
Yale University
Co-authored papers 9
Lei Zhu
Emory University School of Medicine
Co-authored papers 9
Jinxia Guo
Co-authored papers 6
Qingguo Xie
College of Life Science and Technology, Huazhong University of Science and Technology
Co-authored papers 5
Kenneth A Jacobson
National Institutes of Health
Co-authored papers 2
Seulki Lee
The Johns Hopkins University School of Medicine
Co-authored papers 2
Fan Zhang
The Second Hospital of Dalian Medical University
Co-authored papers 2
Abesh Kumar Bhattacharjee
University of California San Diego.
Co-authored papers 2
Kun Zheng
Institute of Chemistry, Chinese Academy of Sciences
Co-authored papers 2
Rong Fan
Institute of Pathogens and Vectors, Dali University
Co-authored papers 2
Chenxi Wu
College of Clinical Medicine, Jining Medical University
Co-authored papers 2
Quanzheng Li
Massachusetts General Hospital
Co-authored papers 2
Martin W Brechbiel
National Institutes of Health
Co-authored papers 1
Cynthia Sung
Health Services and Systems Research, Duke-NUS Medical School
Co-authored papers 1
Raymond T Chung
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 1
Zhifang Wu
The First Hospital of Shanxi Medical University
Co-authored papers 1
Hak Soo Choi
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
Henry S Eden
Co-authored papers 1
Zhan-Guo Gao
National Institutes of Health
Co-authored papers 1
Andrey Loboda
Merck & Co., Inc.
Co-authored papers 1
Xiaomeng Zhang
H. Lee Moffitt Cancer Center
Co-authored papers 1
Mark T Gladwin
University of Maryland School of Medicine
Co-authored papers 1
Peter L Choyke
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Release 1.2